Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 5/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | KDR | P35968 | 1/20 | 0.60 |
| ▸ | ABL1 | P00519 | 4/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | FAAH | O00519 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12978270 | 0.85 | RAB9A (0.74) | RAB9ANPC1EPHX2KMT2AABL1 | |
| SCHEMBL16692450 | 0.84 | NPC1 (0.72) | RAB9ANPC1EPHX2KDM4EMAPT | |
| SCHEMBL22103767 | 0.84 | EPHX2 (0.86) | RAB9ANPC1EPHX2MAPTMEN1 | |
| SCHEMBL11555827 | 0.83 | EPHX2 (1.00) | RAB9ANPC1EPHX2MAPTMEN1 | |
| SCHEMBL1305523 | 0.83 | RAB9A (0.70) | RAB9ANPC1EPHX2KDM4EMAPT | |
| SCHEMBL20379482 | 0.82 | NAMPT (0.71) | RAB9ANPC1MEN1KMT2AL3MBTL1 | |
| SCHEMBL6122991 | 0.82 | ABL1 (0.76) | RAB9ANPC1KMT2AABL1OPRM1 | |
| SCHEMBL30772272 | 0.81 | EPHX2 (0.87) | RAB9ANPC1EPHX2KDM4EMEN1 | |
| SCHEMBL17074387 | 0.81 | NPC1 (0.68) | RAB9ANPC1EPHX2KDM4EMAPT | |
| SCHEMBL9637653 | 0.80 | MEN1 (0.77) | RAB9ANPC1KDM4EMAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210022340-A1 | USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY | THE NATIONAL INSTITUTE OF PARASITIC DISEASES, CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION (CN) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210022340-A1 | USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY | SLC14A1, UACA, UROD | RAB9A 1093/4885NPC1 1905/4885EPHX2 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.